Table 5.
Screening visit (V0) |
Pre-baseline visit (V1) | Baseline visit (V2) |
End of trial visit (V3) | |
Week | −20 to −13 | −9 to −6 | 0 | 10 |
Visit day | 0 | 1 | 2 | 3 |
Informed consent | X | |||
Review of inclusion and exclusion criteria | X | |||
Medical history and examination | X | |||
Randomisation | X* | |||
Registration of medication and adverse events | X | X | X | X |
Anthropometry | ||||
Body weight | X | X | X | X |
Height | X | |||
Waist circumference | X | X | X | X |
Body composition (DXA) | X | X | ||
Biological samples | ||||
Fasting blood sample | X | X | X | |
Saliva sample (SNPs) | X | |||
Urine sample | X | X | X | |
Faecal sample | X† | X† | ||
Nutritional assessment | ||||
Food Frequency Questionnaire | X | X | ||
3-day dietary records | X† | X† | ||
Other measurements | ||||
Blood pressure/heart rate | X | X | X | |
Three factor eating questionnaire | X | X | ||
Perceived Stress Scale | X | X | ||
Behavioural questionnaire (by ONMI) | X | X | ||
Quality of Life questionnaires | X | X | ||
Diet satisfaction questionnaire (DSat-28) | X | X | ||
Money spent on food questions | X | X | ||
Accelerometer (sleep and PA) | X‡ | X‡ |
*Prior to visit.
†At home activity prior to visit.
‡At home activity following the visit.
DXA, dual-energy X-ray absorptiometry; PA, physical activity.